Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia

Luis Martinez-Lostao, Javier Briones, Ignasi Forné, Monica Martinez-Gallo, Beatriz Ferrer, Jordi Sierra, Jose Luis Rodriguez-Sanchez, Candido Juarez

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Signal transducers and activators of transcription (STAT) proteins comprise a family of transcription factors that have been implicated in tumoral transformation, especially in hematological malignancies. Because of this, the JAK/STAT pathway is attractive as a therapeutic target in these tumors. In the present study, we analyzed the ability of fludarabine and two JAK kinase inhibitors, AG490 and WHI-P131, to block STAT1 activation and induce apoptosis on B-cell chronic lymphocytic leukemia (B-CLL) cells. All drugs were able to induce a high percentage of apoptosis on B-CLL cells from all patients studied. However, only AG490 and WHI-P131 were able to strongly suppress the STAT1 activation of B-CLL cells. In conclusion, our data show that JAK kinase inhibitors, such as AG490 and WHI-P131 are able to inhibit the STAT1 pathway on B-CLL cells and are strong inductors of apoptosis on these cells.

Original languageEnglish (US)
Pages (from-to)435-442
Number of pages8
JournalLeukemia and Lymphoma
Volume46
Issue number3
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Janus Kinases
B-Cell Chronic Lymphocytic Leukemia
Apoptosis
STAT Transcription Factors
Hematologic Neoplasms
Transducers
Transcription Factors
fludarabine
Pharmaceutical Preparations
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
WHI P131
Neoplasms

Keywords

  • AG490
  • Apoptosis
  • B-CLL
  • Fludarabine
  • STAT1
  • WHI-P131

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia. / Martinez-Lostao, Luis; Briones, Javier; Forné, Ignasi; Martinez-Gallo, Monica; Ferrer, Beatriz; Sierra, Jordi; Rodriguez-Sanchez, Jose Luis; Juarez, Candido.

In: Leukemia and Lymphoma, Vol. 46, No. 3, 01.03.2005, p. 435-442.

Research output: Contribution to journalArticle

Martinez-Lostao, L, Briones, J, Forné, I, Martinez-Gallo, M, Ferrer, B, Sierra, J, Rodriguez-Sanchez, JL & Juarez, C 2005, 'Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia', Leukemia and Lymphoma, vol. 46, no. 3, pp. 435-442. https://doi.org/10.1080/10428190400018398
Martinez-Lostao, Luis ; Briones, Javier ; Forné, Ignasi ; Martinez-Gallo, Monica ; Ferrer, Beatriz ; Sierra, Jordi ; Rodriguez-Sanchez, Jose Luis ; Juarez, Candido. / Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia. In: Leukemia and Lymphoma. 2005 ; Vol. 46, No. 3. pp. 435-442.
@article{5e71d1eb43fb459aa53ccd23840839d5,
title = "Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia",
abstract = "Signal transducers and activators of transcription (STAT) proteins comprise a family of transcription factors that have been implicated in tumoral transformation, especially in hematological malignancies. Because of this, the JAK/STAT pathway is attractive as a therapeutic target in these tumors. In the present study, we analyzed the ability of fludarabine and two JAK kinase inhibitors, AG490 and WHI-P131, to block STAT1 activation and induce apoptosis on B-cell chronic lymphocytic leukemia (B-CLL) cells. All drugs were able to induce a high percentage of apoptosis on B-CLL cells from all patients studied. However, only AG490 and WHI-P131 were able to strongly suppress the STAT1 activation of B-CLL cells. In conclusion, our data show that JAK kinase inhibitors, such as AG490 and WHI-P131 are able to inhibit the STAT1 pathway on B-CLL cells and are strong inductors of apoptosis on these cells.",
keywords = "AG490, Apoptosis, B-CLL, Fludarabine, STAT1, WHI-P131",
author = "Luis Martinez-Lostao and Javier Briones and Ignasi Forn{\'e} and Monica Martinez-Gallo and Beatriz Ferrer and Jordi Sierra and Rodriguez-Sanchez, {Jose Luis} and Candido Juarez",
year = "2005",
month = "3",
day = "1",
doi = "10.1080/10428190400018398",
language = "English (US)",
volume = "46",
pages = "435--442",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia

AU - Martinez-Lostao, Luis

AU - Briones, Javier

AU - Forné, Ignasi

AU - Martinez-Gallo, Monica

AU - Ferrer, Beatriz

AU - Sierra, Jordi

AU - Rodriguez-Sanchez, Jose Luis

AU - Juarez, Candido

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Signal transducers and activators of transcription (STAT) proteins comprise a family of transcription factors that have been implicated in tumoral transformation, especially in hematological malignancies. Because of this, the JAK/STAT pathway is attractive as a therapeutic target in these tumors. In the present study, we analyzed the ability of fludarabine and two JAK kinase inhibitors, AG490 and WHI-P131, to block STAT1 activation and induce apoptosis on B-cell chronic lymphocytic leukemia (B-CLL) cells. All drugs were able to induce a high percentage of apoptosis on B-CLL cells from all patients studied. However, only AG490 and WHI-P131 were able to strongly suppress the STAT1 activation of B-CLL cells. In conclusion, our data show that JAK kinase inhibitors, such as AG490 and WHI-P131 are able to inhibit the STAT1 pathway on B-CLL cells and are strong inductors of apoptosis on these cells.

AB - Signal transducers and activators of transcription (STAT) proteins comprise a family of transcription factors that have been implicated in tumoral transformation, especially in hematological malignancies. Because of this, the JAK/STAT pathway is attractive as a therapeutic target in these tumors. In the present study, we analyzed the ability of fludarabine and two JAK kinase inhibitors, AG490 and WHI-P131, to block STAT1 activation and induce apoptosis on B-cell chronic lymphocytic leukemia (B-CLL) cells. All drugs were able to induce a high percentage of apoptosis on B-CLL cells from all patients studied. However, only AG490 and WHI-P131 were able to strongly suppress the STAT1 activation of B-CLL cells. In conclusion, our data show that JAK kinase inhibitors, such as AG490 and WHI-P131 are able to inhibit the STAT1 pathway on B-CLL cells and are strong inductors of apoptosis on these cells.

KW - AG490

KW - Apoptosis

KW - B-CLL

KW - Fludarabine

KW - STAT1

KW - WHI-P131

UR - http://www.scopus.com/inward/record.url?scp=13544249962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13544249962&partnerID=8YFLogxK

U2 - 10.1080/10428190400018398

DO - 10.1080/10428190400018398

M3 - Article

C2 - 15621835

AN - SCOPUS:13544249962

VL - 46

SP - 435

EP - 442

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3

ER -